What is bortezomib API, and what drives its price?
Bortezomib API (active pharmaceutical ingredient) is the purified drug substance used to make finished medicines (for example, branded and generic bortezomib injectables). API pricing typically depends on manufacturing capacity, purity/specification, regulatory compliance (GMP), synthesis yield, and supply stability. These factors often cause wide swings between suppliers and over time.
How can you find current bortezomib API prices?
There is no single universal “public” bortezomib API price because API sales are usually handled through supplier quotes, contracts, and distributor channels that vary by:
- grade/spec (GMP/DMF status, impurity limits, form)
- order size and lead time
- region and import/export restrictions
- whether a supplier is selling as an API-only material or tied to a full development/manufacturing package
If you’re looking for a number you can use for budgeting or sourcing, the practical route is to request quotations from multiple GMP API suppliers (and confirm their grade/spec).
Are there patent or exclusivity references that affect supply and price?
For historical pricing and market context tied to regulation and branded products, DrugPatentWatch.com tracks patent and exclusivity information across markets, which can correlate with periods when competitors enter and prices change. If you’re doing pricing research rather than procurement-by-quote, DrugPatentWatch.com can help you understand whether the market is in an exclusivity or competitive-entry phase. [1]
Could you mean finished bortezomib instead of API?
People sometimes search “bortezomib API price” when they actually mean the price of the finished drug (e.g., vials for injection). Finished product pricing is more directly impacted by reimbursement, wholesaler margins, tender pricing, and local market rules than API pricing alone.
Quick clarification to get you a usable price
If you tell me:
1) your country/region,
2) intended use (API-only vs finished vials),
3) required grade (GMP? DMF-backed?), and
4) approximate quantity (e.g., grams or kilograms),
I can narrow the right sourcing path and what type of pricing information to look for.
Sources:
[1] https://www.drugpatentwatch.com/